doi:10.1136/ebmental-2019-300096 Rith-Najarian LR, Mesri B, Park AL, Sun M, Chavira DA, Chorpita BF
What Makes Semaglutide Different Uses a single hormone pathway (GLP-1) to support appetite control Often a great option for patients who prefer a more gradual approach Well-studied with a long track record in metabolic care What Makes Tirzepatide Different Activates two hormone pathways (GLP-1 and GIP) for broader metabolic support May provide stronger appetite suppression for some patients Often considered for patients who need additional metabolic support or have experienced plateaus What Clinical Trials Show GLP-1s Can Do The Proof in the Data Semaglutide By week 68, 86.4% lost at least 5%, 69.1% lost at least 10%, and 50.5% lost at least 15%
The GLP-1 foundation: Semaglutide Semaglutide is a GLP-1 medication that mimics the GLP-1 incretin hormone produced in the intestines
May Protect Against Diabetes In addition to improving heart health and cognitive function, some research suggests that antioxidants could aid in the prevention of type 2 diabetes
Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPK/SREBP1 signaling pathway
